LE
Larry Todd Edwards
See Remarks

Larry Todd Edwards insider trades: Arcutis Biotherapeutics (ARQT) stock buys and sales

See Remarks, Arcutis Biotherapeutics Last trade Feb 2, 2026 12 Form 4 filings
$785K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2024
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Larry reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 2, 2026ARQT↓ Sell$52K
Nov 6, 2025ARQT↓ Sell$733K
Oct 2, 2025ARQT↓ Sell$90K
May 19, 2025ARQT↓ Sell$105K
Feb 3, 2025ARQT↓ Sell$28K
Nov 30, 2024ARQT↑ Buy$8K
Oct 2, 2024ARQT↓ Sell$37K
May 17, 2024ARQT↓ Sell$69K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ARQT insiders

Open-market trades in the last 12 months

About Larry Todd Edwards's insider trades

Larry Todd Edwards is See Remarks at Arcutis Biotherapeutics (ARQT). Since May 17, 2024, Larry has reported 1 open-market purchase worth $8K and 7 sales worth $1.1M on SEC Form 4. In the last 12 months: 2 sales ($785K).

Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARQT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.